STING1 and fatty liver disease: In contrast, the HFD-fed mice without expressing STING (which carried a point mutation in STING T596A leading to no detectable protein) showed a reduction in hepatic steatosis (accumulation of fat in the liver), inflammation, and fibrosis (Papatheodoridi et al., 2020).